UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 9, 2009
HELICOS BIOSCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware |
| 001-33484 |
| 05-0587367 |
(State or Other Jurisdiction |
| (Commission File Number) |
| (IRS Employer |
of Incorporation) |
|
|
| Identification No.) |
|
|
|
|
|
One Kendall Square |
| 02139 | ||
(Address of Principal Executive Offices) |
| (Zip Code) |
(617) 264-1800
(Registrant’s telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 9, 2009, the Compensation Committee of the Board of Directors of Helicos BioSciences Corporation (“Helicos” or the “Company”) decided to renew the monthly housing allowance for Stephen P. Hall, Senior Vice President, Chief Financial Officer and Treasurer of Helicos for an additional six month period. Mr. Hall’s housing allowance is provided in a lump sum payment of $3,000 per month and is treated as a taxable benefit for Mr. Hall. In addition, the Compensation Committee approved the Company’s reimbursement of Mr. Hall’s ongoing commuting expenses to and from the Company’s Cambridge, Massachusetts headquarters together with a gross up of such reimbursement for taxes for an additional six month period.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HELICOS BIOSCIENCES CORPORATION | |
|
|
|
|
|
|
| By: | /s/ Ronald A. Lowy |
Date: April 10, 2009 | Name: Ronald A. Lowy | |
| Title: Chief Executive Officer |
3